AKRO INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Akero Therapeutics, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case
), the Akero class action lawsuit charges Akero as well as certain of its top executive officers with violations of the Securities Exchange Act of 1934.
- ), the Akero class action lawsuit charges Akero as well as certain of its top executive officers with violations of the Securities Exchange Act of 1934.
- Lead plaintiff motions for the Akero class action lawsuit must be filed with the court no later than June 25, 2024.
- A lead plaintiff acts on behalf of all other class members in directing the Akero class action lawsuit.
- An investor’s ability to share in any potential future recovery of the Akero class action lawsuit is not dependent upon serving as lead plaintiff.